Majdi, A., Aoudjehane, L., Ratziu, V., Islam, T., Afonso, M. B., Conti, F., . . . Gautheron, J. (2020). Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease.
Chicago Style (17th ed.) CitationMajdi, Amine, et al. Inhibition of Receptor-interacting Protein Kinase 1 Improves Experimental Non-alcoholic Fatty Liver Disease. 2020.
MLA (8th ed.) CitationMajdi, Amine, et al. Inhibition of Receptor-interacting Protein Kinase 1 Improves Experimental Non-alcoholic Fatty Liver Disease. 2020.
Warning: These citations may not always be 100% accurate.